Cancers are heterogeneous in biology among patients, tumors in the same patient, and within tumors. As a result, they respond differently to therapy per patient, per tumor and within tumors. Different radiotracers and imaging modalities provide information about different aspects of biology and the physio-metabolic environments of the cancer. As a result, a single modality or radiotracer may not provide sufficient information to predict or assess response to therapy. We hypothesize that improved prediction and assessment of response can thus be obtained by combining quantitative image-derived parameters obtained from multiple imaging modalities or radiotracers. We propose to develop, optimize, and validate approaches for combining multiple image-derived parameters obtained from quantitative imaging procedures in order to optimally predict and assess treatment response. In particular, we propose to combine quantitative metrics from PET/CT, SPECT/CT, and MRI. We will first individually optimize the protocols, acquisition parameters, and imaging methods in order to get the most accurate and reliable parameters to combine. Optimally combining the parameters from different modalities requires knowledge of the reproducibility (precision) of the individual quantitative imaging parameters. We will thus use literature search, phantom studies, realistic simulations, and repeated patient studies to characterize the accuracy and precision of the individual quantitative imaging methods. We will then develop methods to combine the metrics to predict or assess treatment response per patient, per tumor and intra-tumor. We will apply and evaluate these methods in three clinical trials: dynamic and static FDG and FIT PET/CT to assess lung cancer response to cytotoxic chemotherapy;PET/CT and DCE- and DW-MRI in breast cancer response;and SPECT/CT, PET/CT and DCE- and DW-MRI to predict response of brain tumors to anti-angiogenic therapy. In these trials imaging parameters and their signatures will be linked to histology or survival outcomes to provide validation of the combined imaging parameter metrics.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Nordstrom, Robert J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Schools of Medicine
United States
Zip Code
Jacobs, Michael A; Macura, Katarzyna J; Zaheer, Atif et al. (2018) Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors. Acad Radiol 25:1405-1414
Malyarenko, Dariya; Fedorov, Andriy; Bell, Laura et al. (2018) Toward uniform implementation of parametric map Digital Imaging and Communication in Medicine standard in multisite quantitative diffusion imaging studies. J Med Imaging (Bellingham) 5:011006
Newitt, David C; Malyarenko, Dariya; Chenevert, Thomas L et al. (2018) Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network. J Med Imaging (Bellingham) 5:011003
Jha, Abhinav K; Mena, Esther; Caffo, Brian et al. (2017) Practical no-gold-standard evaluation framework for quantitative imaging methods: application to lesion segmentation in positron emission tomography. J Med Imaging (Bellingham) 4:011011
Lodge, Martin A (2017) Repeatability of SUV in Oncologic 18F-FDG PET. J Nucl Med 58:523-532
Lodge, Martin A; Holdhoff, Matthias; Leal, Jeffrey P et al. (2017) Repeatability of (18)F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma. J Nucl Med 58:393-398
Mena, Esther; Taghipour, Mehdi; Sheikhbahaei, Sara et al. (2017) Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma. Clin Nucl Med 42:e227-e234
Vicente, Esther M; Lodge, Martin A; Rowe, Steven P et al. (2017) Simplifying volumes-of-interest (VOIs) definition in quantitative SPECT: Beyond manual definition of 3D whole-organ VOIs. Med Phys 44:1707-1717
Parekh, Vishwa S; Jacobs, Michael A (2017) Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI. NPJ Breast Cancer 3:43
Crandall, John P; Tahari, Abdel K; Juergens, Rosalyn A et al. (2017) A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC. EJNMMI Res 7:8

Showing the most recent 10 out of 60 publications